Fig. 1: Prevalence of MetS in PD patients and control subjects in the years before the DoD. | npj Parkinson's Disease

Fig. 1: Prevalence of MetS in PD patients and control subjects in the years before the DoD.

From: Lower prevalence of metabolic syndrome and its components in the prediagnostic phase of Parkinson’s disease

Fig. 1

The graph is a collection of points, each representing the prevalence in a specific year until the DoD (red dashed vertical line). The results are calculated on the basis of data collected in the previous year; for example, “−3” relates to the prevalence calculated during the fourth year (from year 3 to year 4) before the DoD. For controls, the DoD is defined by the DoD of their matched patient (see the Methods section). a Whole cohort. b Stratification by sex. Numbers in the figure indicate the annual count (averaged over 10 datasets) of PD patients and control subjects meeting the criteria for MetS before the DoD.

Back to article page